Insights in Gynecologic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Current Trends Gynecol Oncol : 8; 167,
  • DOI: 10.4172/ctgo.1000167

Resistance to Chemotherapy in Uterine Cancer: Mechanisms and Current therapies for Systemic treatment of Gynaecologic Malignancies

Routhu Gustavo*
Department of Obstetrics and Gynaecology, Columbia University College of Physicians and Surgeons, United States
*Corresponding Author : Routhu Gustavo, Department of Obstetrics and Gynaecology, Columbia University College of Physicians and Surgeons, United States, Email: Gustavo@yahoo.co.in

Received Date: Aug 01, 2023 / Published Date: Aug 30, 2023

Abstract

Uterine cancer, also known as endometrial cancer, is a type of cancer that originates in the lining of the uterus, called the endometrium. It is one of the most common gynecological cancers among women, primarily affecting those who have reached or are approaching menopause. Uterine cancer develops when the cells in the endometrium begin to grow uncontrollably, forming a tumor. This type of cancer can present various symptoms, such as abnormal vaginal bleeding (including post-menopausal bleeding), pelvic pain, and unusual vaginal discharge. While the exact cause of uterine cancer is not always clear, several risk factors, including hormonal imbalances, obesity, a family history of uterine or colon cancer, and certain medical conditions like polycystic ovary syndrome (PCOS), may increase the likelihood of its development.

Citation: Gustavo R (2023) Resistance to Chemotherapy in Uterine Cancer: Mechanisms and Current therapies for Systemic treatment of Gynaecologic Malignancies. Current Trends Gynecol Oncol, 8: 167. Doi: 10.4172/ctgo.1000167

Copyright: © 2023 Gustavo R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top